1,450 research outputs found

    A Class of Free Boundary Problems with Onset of a new Phase

    Full text link
    A class of diffusion driven Free Boundary Problems is considered which is characterized by the initial onset of a phase and by an explicit kinematic condition for the evolution of the free boundary. By a domain fixing change of variables it naturally leads to coupled systems comprised of a singular parabolic initial boundary value problem and a Hamilton-Jacobi equation. Even though the one dimensional case has been thoroughly investigated, results as basic as well-posedness and regularity have so far not been obtained for its higher dimensional counterpart. In this paper a recently developed regularity theory for abstract singular parabolic Cauchy problems is utilized to obtain the first well-posedness results for the Free Boundary Problems under consideration. The derivation of elliptic regularity results for the underlying static singular problems will play an important role

    Opening the black box: a primer for anti-discrimination

    Get PDF
    The pervasive adoption of Artificial Intelligence (AI) models in the modern information society, requires counterbalancing the growing decision power demanded to AI models with risk assessment methodologies. In this paper, we consider the risk of discriminatory decisions and review approaches for discovering discrimination and for designing fair AI models. We highlight the tight relations between discrimination discovery and explainable AI, with the latter being a more general approach for understanding the behavior of black boxes

    GLocalX - From Local to Global Explanations of Black Box AI Models

    Get PDF
    Artificial Intelligence (AI) has come to prominence as one of the major components of our society, with applications in most aspects of our lives. In this field, complex and highly nonlinear machine learning models such as ensemble models, deep neural networks, and Support Vector Machines have consistently shown remarkable accuracy in solving complex tasks. Although accurate, AI models often are “black boxes” which we are not able to understand. Relying on these models has a multifaceted impact and raises significant concerns about their transparency. Applications in sensitive and critical domains are a strong motivational factor in trying to understand the behavior of black boxes. We propose to address this issue by providing an interpretable layer on top of black box models by aggregating “local” explanations. We present GLOCALX, a “local-first” model agnostic explanation method. Starting from local explanations expressed in form of local decision rules, GLOCALX iteratively generalizes them into global explanations by hierarchically aggregating them. Our goal is to learn accurate yet simple interpretable models to emulate the given black box, and, if possible, replace it entirely. We validate GLOCALX in a set of experiments in standard and constrained settings with limited or no access to either data or local explanations. Experiments show that GLOCALX is able to accurately emulate several models with simple and small models, reaching state-of-the-art performance against natively global solutions. Our findings show how it is often possible to achieve a high level of both accuracy and comprehensibility of classification models, even in complex domains with high-dimensional data, without necessarily trading one property for the other. This is a key requirement for a trustworthy AI, necessary for adoption in high-stakes decision making applications.Artificial Intelligence (AI) has come to prominence as one of the major components of our society, with applications in most aspects of our lives. In this field, complex and highly nonlinear machine learning models such as ensemble models, deep neural networks, and Support Vector Machines have consistently shown remarkable accuracy in solving complex tasks. Although accurate, AI models often are “black boxes” which we are not able to understand. Relying on these models has a multifaceted impact and raises significant concerns about their transparency. Applications in sensitive and critical domains are a strong motivational factor in trying to understand the behavior of black boxes. We propose to address this issue by providing an interpretable layer on top of black box models by aggregating “local” explanations. We present GLOCALX, a “local-first” model agnostic explanation method. Starting from local explanations expressed in form of local decision rules, GLOCALX iteratively generalizes them into global explanations by hierarchically aggregating them. Our goal is to learn accurate yet simple interpretable models to emulate the given black box, and, if possible, replace it entirely. We validate GLOCALX in a set of experiments in standard and constrained settings with limited or no access to either data or local explanations. Experiments show that GLOCALX is able to accurately emulate several models with simple and small models, reaching state-of-the-art performance against natively global solutions. Our findings show how it is often possible to achieve a high level of both accuracy and comprehensibility of classification models, even in complex domains with high-dimensional data, without necessarily trading one property for the other. This is a key requirement for a trustworthy AI, necessary for adoption in high-stakes decision making applications

    A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany

    Get PDF
    Background: Worldwide healthcare systems face challenges in assessing and monitoring chronic care pathways and, even more, the value generated for patients. Patient-reported outcomes measures (PROMs) represent a valid Real-World Evidence (RWE) source to fully assess health systems’ performance in managing chronic care pathways. Methods: The originality of the study consists in the chance of adopting PROMs, as a longitudinal assessment tool for continuous monitoring of patients’ adherence to therapies and self-care behavior recommendations in clinical practice and as a chance to provide policy makers insights to improve chronic pathways adopting a patient perspective. The focus was on PROMs of patients with chronic heart failure (CHF) collected in the Gabriele Monasterio Tuscan Foundation (FTGM), a tertiary referral CHF centre in Pisa, Italy. During the hospital stay, CHF patients were enrolled and received a link (via SMS or email) to access to the first questionnaire. Follow-up questionnaires were sent 1, 7 and 12 months after the index hospitalisation. Professionals invited 200 patients to participate to PROMs surveys. 174 answers were digitally collected at baseline from 2018 to 2020 and analysed. Quantitative and qualitative analyses were conducted, using Chi2, t-tests and regression models together with narrative evidence from free text responses. Results: Both quantitative and qualitative results showed FTGM patients declared to strongly adhere to the pharmacological therapy across the entire pathway, while seemed less careful to adhere to self-care behavior recommendations (e.g., physical activity). CHF patients that performed adequate Self-Care Maintenance registered outcome improvements. Respondents declared to be supported by family members in managing their adherence. Conclusions: The features of such PROMs collection model are relevant for researchers, policymakers and for managers to implement interventions aimed at improving pathway adherence dimensions. Among those, behavioral economics interventions could be implemented to increase physical activity among CHF patients since proven successful in Tuscany. Strategies to increase territorial care and support patients’ caregivers in their daily support to patients’ adherence should be further explored. Systematic PROMs collection would allow to monitor changes in the whole pathway organization. This study brings opportunities for extending such monitoring systems to other organizations to allow for reliable benchmarking opportunities

    Tight Regulation of Mechanotransducer Proteins Distinguishes the Response of Adult Multipotent Mesenchymal Cells on PBCE-Derivative Polymer Films with Different Hydrophilicity and Stiffness

    Get PDF
    : Mechanotransduction is a molecular process by which cells translate physical stimuli exerted by the external environment into biochemical pathways to orchestrate the cellular shape and function. Even with the advancements in the field, the molecular events leading to the signal cascade are still unclear. The current biotechnology of tissue engineering offers the opportunity to study in vitro the effect of the physical stimuli exerted by biomaterial on stem cells and the mechanotransduction pathway involved in the process. Here, we cultured multipotent human mesenchymal/stromal cells (hMSCs) isolated from bone marrow (hBM-MSCs) and adipose tissue (hASCs) on films of poly(butylene 1,4-cyclohexane dicarboxylate) (PBCE) and a PBCE-based copolymer containing 50 mol% of butylene diglycolate co-units (BDG50), to intentionally tune the surface hydrophilicity and the stiffness (PBCE = 560 Mpa; BDG50 = 94 MPa). We demonstrated the activated distinctive mechanotransduction pathways, resulting in the acquisition of an elongated shape in hBM-MSCs on the BDG50 film and in maintaining the canonical morphology on the PBCE film. Notably, hASCs acquired a new, elongated morphology on both the PBCE and BDG50 films. We found that these events were mainly due to the differences in the expression of Cofilin1, Vimentin, Filamin A, and Talin, which established highly sensitive machinery by which, rather than hASCs, hBM-MSCs distinguished PBCE from BDG50 films

    In vitro antileishmanial activity of trans-stilbene and terphenyl compounds

    Get PDF
    Leishmaniasis are globally widespread parasitic diseases which often leads to death if left untreated. Currently available drugs present different drawbacks, so there is an urgent need to develop new, safe and cost-effective drugs against leishmaniasis. In this study we tested a small library of trans-stilbene and terphenyl derivatives against promastigote, amastigotes and intramacrophage amastigote forms of Leishmania infantum. Two compounds of the series, the trans-stilbene 3 and the terphenyl 11, presented the best activity and safety profiles. Terphenyl 11 showed a leshmanicidal activity higher than pentostam and the ability to induce apoptosis selectively in Leishmania infantum while saving macrophages and primary epithelial cells. Our data indicate that terphenyl compounds, as well as stilbenes, are endowed with leishmanicidal activity, showing potential for further studies in the context of leishmanial therapy

    Early detection of poor glycemic control in patients with diabetes mellitus in sub-Saharan Africa: a cohort study in Mozambique

    Get PDF
    Introduction: WHO estimates 422 million cases of diabetes mellitus worldwide. Mozambique has the second-highest mortality related to DM in the African region. Objectives of the present study are to provide data about a DM care service in Mozambique and to evaluate early outcomes of treatment. Methods: The new patients diagnosed with DM in a two-years period in a health centre in Maputo (Mozambique) were included in a retrospective cohort study. Fasting blood glucose (FBG), waist circumference (WC) and BMI were collected at baseline and after three months. Results: 188 patients were enrolled. Median BMI, WC and FBG at baseline were respectively 28 kg/m2(Inter Quartile Range [IQR]23.4-31.8), 98cm (IQR 87-105) and 209mg/dL (IQR 143-295). A non-pharmacological intervention was prescribed for six patients, while 182 patients received metformin 500 mg b.i.d. FBG was significantly reduced at control (226[±103.7]mg/dL vs 186[±93.2]mg/dL, p<0.000); however, glycemic control was reached in 74 patients (39.4%); not controlled patients changed regimen. Elderly patients had a higher glycemic control (adjusted Odds Ratio 2.50, 95% CI 1.11-5.06, p=0.002). Conclusion: Strategies for early detection of scarce glycemic control are feasible in Mozambique and could lead to prompt regimen switch; an invasive therapeutic approach could be preferable in selected cases to achieve control

    Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.

    Get PDF
    The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative activity. The goal of this study was to identify molecular biomarkers in nAMD with incomplete response to anti-VEGF treatment. Aqueous humor (AH) samples were collected from three groups of patients: 17 patients with nAMD responding incompletely to anti-VEGF (18 eyes), 17 patients affected by nAMD with normal treatment response (21 eyes), and 16 control patients without any retinopathy (16 eyes). Proteomic and multiplex analyses were performed on these samples. Proteomic analyses showed that nAMD patients with incomplete anti-VEGF response displayed an increased inflammatory response, complement activation, cytolysis, protein-lipid complex, and vasculature development pathways. Multiplex analyses revealed a significant increase of soluble vascular cell adhesion molecule-1 (sVCAM-1) [ p = 0.001], interleukin-6 (IL-6) [ p = 0.009], bioactive interleukin-12 (IL-12p40) [ p = 0.03], plasminogen activator inhibitor type 1 (PAI-1) [ p = 0.004], and hepatocyte growth factor (HGF) [ p = 0.004] levels in incomplete responders in comparison to normal responders. Interestingly, the same biomarkers showed a high intercorrelation with r2 values between 0.58 and 0.94. In addition, we confirmed by AlphaLISA the increase of sVCAM-1 [ p < 0.0001] and IL-6 [ p = 0.043] in the incomplete responder group. Incomplete responders in nAMD are associated with activated angiogenic and inflammatory pathways. The residual exudative activity of nAMD despite maximal anti-VEGF treatment may be related to both angiogenic and inflammatory responses requiring specific adjuvant therapy. Data are available via ProteomeXchange with identifier PXD02247
    • 

    corecore